Cellectis SA (CLLS)
3.21
-0.20
(-5.73%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
0.00 (0.00%)
After-Hours: 20:00
Cellectis Shareholders Equity (Quarterly) : 41.07M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 41.07M |
| March 31, 2026 | 59.92M |
| December 31, 2025 | 75.90M |
| September 30, 2025 | 100.48M |
| June 30, 2025 | 97.11M |
| March 31, 2025 | 116.20M |
| December 31, 2024 | 131.03M |
| September 30, 2024 | 129.42M |
| June 30, 2024 | 148.61M |
| March 31, 2024 | 90.57M |
| December 31, 2023 | 84.70M |
| September 30, 2023 | 76.12M |
| June 30, 2023 | 96.56M |
| March 31, 2023 | 113.74M |
| December 31, 2022 | 117.97M |
| September 30, 2022 | 136.64M |
| June 30, 2022 | 168.93M |
| March 31, 2022 | 191.04M |
| December 31, 2021 | 221.29M |
| September 30, 2021 | 237.97M |
| June 30, 2021 | 275.86M |
| March 31, 2021 | 261.93M |
| December 31, 2020 | 275.57M |
| Date | Value |
|---|---|
| September 30, 2020 | 290.37M |
| June 30, 2020 | 307.61M |
| March 31, 2020 | 331.84M |
| December 31, 2019 | 315.12M |
| September 30, 2019 | 340.64M |
| June 30, 2019 | 363.82M |
| March 31, 2019 | 391.15M |
| December 31, 2018 | 409.30M |
| September 30, 2018 | 430.65M |
| June 30, 2018 | 447.73M |
| March 31, 2018 | 255.32M |
| December 31, 2017 | 266.79M |
| September 30, 2017 | 283.28M |
| June 30, 2017 | 267.08M |
| March 31, 2017 | 269.47M |
| December 31, 2016 | 272.96M |
| September 30, 2016 | 284.99M |
| June 30, 2016 | 283.14M |
| March 31, 2016 | 279.31M |
| December 31, 2015 | 285.58M |
| September 30, 2015 | 267.13M |
| June 30, 2015 | 270.81M |
| March 31, 2015 | 281.25M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Akari Therapeutics Plc | 18.60M |
| EDAP TMS SA | -3.225M |
| Autolus Therapeutics Plc | 74.84M |
| Evaxion AS | 9.531M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 267.36M |
| Total Liabilities (Quarterly) | 226.30M |
| Debt to Equity Ratio | 2.539 |
| Current Ratio | 1.366 |
| Net Debt Paydown Yield | 0.30% |